<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   1184
  </number>
  <updateDate>
   2023-01-11T13:47:19Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:47:19Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-18
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 31 (Thursday, February 18, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. TONKO:H.R. 1184.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3[Page H538]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-19T22:46:53Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-18T17:30:46Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-02-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     T000469
    </bioguideId>
    <fullName>
     Rep. Tonko, Paul [D-NY-20]
    </fullName>
    <firstName>
     Paul
    </firstName>
    <lastName>
     Tonko
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     20
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     M001180
    </bioguideId>
    <fullName>
     Rep. McKinley, David B. [R-WV-1]
    </fullName>
    <firstName>
     David
    </firstName>
    <lastName>
     McKinley
    </lastName>
    <party>
     R
    </party>
    <state>
     WV
    </state>
    <middleName>
     B.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-02-18
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     F000466
    </bioguideId>
    <fullName>
     Rep. Fitzpatrick, Brian K. [R-PA-1]
    </fullName>
    <firstName>
     Brian
    </firstName>
    <lastName>
     Fitzpatrick
    </lastName>
    <party>
     R
    </party>
    <state>
     PA
    </state>
    <middleName>
     K.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-02-18
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001204
    </bioguideId>
    <fullName>
     Del. San Nicolas, Michael F. Q. [D-GU-At Large]
    </fullName>
    <firstName>
     Michael
    </firstName>
    <lastName>
     San Nicolas
    </lastName>
    <party>
     D
    </party>
    <state>
     GU
    </state>
    <middleName>
     F. Q.
    </middleName>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-02-18
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000032
    </bioguideId>
    <fullName>
     Rep. Jackson Lee, Sheila [D-TX-18]
    </fullName>
    <firstName>
     SHEILA
    </firstName>
    <lastName>
     JACKSON LEE
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     18
    </district>
    <sponsorshipDate>
     2021-03-09
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     H000324
    </bioguideId>
    <fullName>
     Rep. Hastings, Alcee L. [D-FL-20]
    </fullName>
    <firstName>
     ALCEE
    </firstName>
    <lastName>
     HASTINGS
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     L.
    </middleName>
    <district>
     20
    </district>
    <sponsorshipDate>
     2021-03-17
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001202
    </bioguideId>
    <fullName>
     Rep. Murphy, Stephanie N. [D-FL-7]
    </fullName>
    <firstName>
     Stephanie
    </firstName>
    <lastName>
     Murphy
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     N.
    </middleName>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-04-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000478
    </bioguideId>
    <fullName>
     Rep. Tenney, Claudia [R-NY-22]
    </fullName>
    <firstName>
     Claudia
    </firstName>
    <lastName>
     Tenney
    </lastName>
    <party>
     R
    </party>
    <state>
     NY
    </state>
    <district>
     22
    </district>
    <sponsorshipDate>
     2021-05-12
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001298
    </bioguideId>
    <fullName>
     Rep. Bacon, Don [R-NE-2]
    </fullName>
    <firstName>
     Don
    </firstName>
    <lastName>
     Bacon
    </lastName>
    <party>
     R
    </party>
    <state>
     NE
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2022-02-25
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001193
    </bioguideId>
    <fullName>
     Rep. Swalwell, Eric [D-CA-15]
    </fullName>
    <firstName>
     Eric
    </firstName>
    <lastName>
     Swalwell
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     15
    </district>
    <sponsorshipDate>
     2022-09-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Drug therapy
     </name>
    </item>
    <item>
     <name>
      European Union
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health information and medical records
     </name>
    </item>
    <item>
     <name>
      Licensing and registrations
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-18
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-29T21:37:07Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Helping Experts Accelerate Rare Treatments Act of 2021 &lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.&lt;/p&gt; &lt;p&gt;The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as &lt;i&gt;orphan drugs &lt;/i&gt;if the rarity of the disease makes it difficult for the drug to be profitable).&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Helping Experts Accelerate Rare Treatments Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Helping Experts Accelerate Rare Treatments Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Helping Experts Accelerate Rare Treatments Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-18T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr1184ih/xml/BILLS-117hr1184ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-19
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-18
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
2021-02-18T17:30:46Z
Referred to
House
Energy and Commerce Committee
2021-02-19T22:46:53Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-02-18
WV
F000466
1
Brian
Rep. Fitzpatrick, Brian K. [R-PA-1]
Fitzpatrick
K.
R
2021-02-18
PA
S001204
0
Michael
Del. San Nicolas, Michael F. Q. [D-GU-At Large]
San Nicolas
F. Q.
D
2021-02-18
GU
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-03-09
TX
H000324
20
ALCEE
Rep. Hastings, Alcee L. [D-FL-20]
HASTINGS
L.
D
2021-03-17
FL
M001202
7
Stephanie
Rep. Murphy, Stephanie N. [D-FL-7]
Murphy
N.
D
2021-04-26
FL
T000478
22
Claudia
Rep. Tenney, Claudia [R-NY-22]
Tenney
R
2021-05-12
NY
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2022-02-25
NE
S001193
15
Eric
Rep. Swalwell, Eric [D-CA-15]
Swalwell
D
2022-09-28
CA
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-18
2021-02-19
Referred to the Subcommittee on Health.
House
Health
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
N
Tonko
D
NY
Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy European Union Government information and archives Government studies and investigations Health care coverage and access Health information and medical records Licensing and registrations Prescription drugs
2021-02-18
Introduced in House
 <p><b>Helping Experts Accelerate Rare Treatments Act of 2021 </b></p> <p>This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.</p> <p>The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as <i>orphan drugs </i>if the rarity of the disease makes it difficult for the drug to be profitable).</p>
2021-03-29T21:37:07Z
00
2021-02-18T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr1184ih/xml/BILLS-117hr1184ih.xml
Helping Experts Accelerate Rare Treatments Act of 2021
Helping Experts Accelerate Rare Treatments Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Helping Experts Accelerate Rare Treatments Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:47:19Z
2023-01-11T13:47:19Z
3.0.0
2021-02-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-18
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
N
Tonko
D
NY
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-02-18
WV
F000466
1
Brian
Rep. Fitzpatrick, Brian K. [R-PA-1]
Fitzpatrick
K.
R
2021-02-18
PA
S001204
0
Michael
Del. San Nicolas, Michael F. Q. [D-GU-At Large]
San Nicolas
F. Q.
D
2021-02-18
GU
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-03-09
TX
H000324
20
ALCEE
Rep. Hastings, Alcee L. [D-FL-20]
HASTINGS
L.
D
2021-03-17
FL
M001202
7
Stephanie
Rep. Murphy, Stephanie N. [D-FL-7]
Murphy
N.
D
2021-04-26
FL
T000478
22
Claudia
Rep. Tenney, Claudia [R-NY-22]
Tenney
R
2021-05-12
NY
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2022-02-25
NE
S001193
15
Eric
Rep. Swalwell, Eric [D-CA-15]
Swalwell
D
2022-09-28
CA
Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy European Union Government information and archives Government studies and investigations Health care coverage and access Health information and medical records Licensing and registrations Prescription drugs
2021-02-18
Introduced in House
 <p><b>Helping Experts Accelerate Rare Treatments Act of 2021 </b></p> <p>This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.</p> <p>The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as <i>orphan drugs </i>if the rarity of the disease makes it difficult for the drug to be profitable).</p>
2021-03-29T21:37:07Z
00
Helping Experts Accelerate Rare Treatments Act of 2021
Helping Experts Accelerate Rare Treatments Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Helping Experts Accelerate Rare Treatments Act of 2021
Short Title(s) as Introduced
2021-02-19
Referred to the Subcommittee on Health.